ANDREW PAULSON, MD
Medical Oncology Physician · DALLAS, TX
Individual Active NPI 1821257072
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 480 | 87,628 | $8,258,110 | $2,314,417 | $1,847,898 |
| 2023 | 434 | 61,231 | $5,727,788 | $1,628,737 | $1,298,371 |
| 2022 | 541 | 77,654 | $6,966,895 | $2,156,601 | $1,722,746 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1453 | Injection, fosaprepitant, 1 mg | 10,650 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 8,800 | $56 | $45 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,779 | $0 | $0 |
| J1930 | Injection, lanreotide, 1 mg | 5,760 | $47 | $38 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 5,600 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,220 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 3,575 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 3,440 | $31 | $25 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,436 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,030 | $1 | $1 |
| 80053 | Blood test, comprehensive group of blood chemicals | 558 | $10 | $10 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 540 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | P9108 | TX |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1962595090
- NPI 1407898505
- NPI 1225328743
- NPI 1528591047
- NPI 1326368895
- NPI 1154530830
- NPI 1235171281
- NPI 1902980014
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.